Literature DB >> 25664478

Behaviour of four different B16 murine melanoma cell sublines: C57BL/6J skin.

Corina Danciu1, Camelia Oprean2, Dorina E Coricovac3, Cioca Andreea4, Anca Cimpean5, Heinfried Radeke6, Codruta Soica2, Cristina Dehelean3.   

Abstract

Transplantable murine melanomas are well-established models for the study of experimental cancer therapies. The aim of this study was to explore the behaviour of four different B16 murine melanoma cell sublines after inoculation into C57BL/6J mice; and, more specifically to analyse skin changes, with respect to two specific parameters: clinical (tumour volume, melanin amount, erythema) and histological (H & E, S100, VEGF expression). Both non-invasive and invasive analysis showed that B164A5 is the most aggressive melanoma cell line for C57BL/6J's skin, followed by B16F10 and then by diminished aggressive growth pattern by the B16GMCSF and B16FLT3 cell lines.
© 2015 The Authors. International Journal of Experimental Pathology © 2015 International Journal of Experimental Pathology.

Entities:  

Keywords:  B164A5; B16F10; B16FLT3; B16GMCSF; C57BL/6J

Mesh：

Substances：

Year:  2015        PMID： 25664478      PMCID： PMC4459798          DOI： 10.1111/iep.12114

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN： 0959-9673            Impact factor:   1.925


  40 in total

1.  Suppression of melanin production by expression of HSP70.

Authors:  Tatsuya Hoshino; Minoru Matsuda; Yasuhiro Yamashita; Masaya Takehara; Masayo Fukuya; Kazutaka Mineda; Daisuke Maji; Hironobu Ihn; Hiroaki Adachi; Gen Sobue; Yoko Funasaka; Tohru Mizushima
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

2.  Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth.

Authors:  Mee-Hyun Lee; Zunnan Huang; Dong Joon Kim; Sung-Hyun Kim; Myoung Ok Kim; Sung-Young Lee; Hua Xie; Si Jun Park; Jae Young Kim; Joydeb Kumar Kundu; Ann M Bode; Young-Joon Surh; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2013-02-27

3.  Serum S100--a marker for disease monitoring in metastatic melanoma.

Authors:  G Henze; R Dummer; H I Joller-Jemelka; R Böni; G Burg
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

4.  A novel form of melanoma apoptosis resistance: melanogenesis up-regulation in apoptotic B16-F0 cells delays ursolic acid-triggered cell death.

Authors:  Aline Pinon; Youness Limami; Ludovic Micallef; Jeanne Cook-Moreau; Bertrand Liagre; Christiane Delage; Raphaël Emmanuel Duval; Alain Simon
Journal:  Exp Cell Res       Date:  2011-05-03       Impact factor: 3.905

5.  Dietary glycine inhibits the growth of B16 melanoma tumors in mice.

Authors:  M L Rose; J Madren; H Bunzendahl; R G Thurman
Journal:  Carcinogenesis       Date:  1999-05       Impact factor: 4.944

6.  Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota.

Authors:  Kurtis B Reed; Jerry D Brewer; Christine M Lohse; Kariline E Bringe; Crystal N Pruitt; Lawrence E Gibson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

7.  Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.

Authors:  John Stagg; Jian Hui Wu; Nathaniel Bouganim; Jacques Galipeau
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

8.  Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy.

Authors:  Anna A Brozyna; Lester VanMiddlesworth; Andrzej T Slominski
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

9.  Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice.

Authors:  R Giavazzi; D E Campbell; J M Jessup; K Cleary; I J Fidler
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

10.  Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors.

Authors:  Michael A Curran; James P Allison
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701
View more
  10 in total

1.  Screening of plants from the Brazilian Atlantic Forest led to the identification of Athenaea velutina (Solanaceae) as a novel source of antimetastatic agents.

Authors:  Alisson A Almeida; Graziela D A Lima; Marcos V R C Simão; Gabriela A Moreira; Raoni P Siqueira; Ana C Zanatta; Wagner Vilegas; Mariana Machado-Neves; Gustavo C Bressan; João P V Leite
Journal:  Int J Exp Pathol       Date:  2020-05-26       Impact factor: 1.925

2.  Effects of ursolic and oleanolic on SK‑MEL‑2 melanoma cells: In vitro and in vivo assays.

Authors:  Angela Caunii; Camelia Oprean; Mirabela Cristea; Alexandra Ivan; Corina Danciu; Calin Tatu; Virgil Paunescu; Daniela Marti; George Tzanakakis; Demetrios A Spandidos; Aristides Tsatsakis; Razvan Susan; Codruta Soica; Stefana Avram; Cristina Dehelean
Journal:  Int J Oncol       Date:  2017-10-16       Impact factor: 5.650

3.  Biocompatible Colloidal Suspensions Based on Magnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Toxicological Profile.

Authors:  Dorina-Elena Coricovac; Elena-Alina Moacă; Iulia Pinzaru; Cosmin Cîtu; Codruta Soica; Ciprian-Valentin Mihali; Cornelia Păcurariu; Victor A Tutelyan; Aristidis Tsatsakis; Cristina-Adriana Dehelean
Journal:  Front Pharmacol       Date:  2017-03-28       Impact factor: 5.810

4.  Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice.

Authors:  Marine Potez; Verdiana Trappetti; Audrey Bouchet; Cristian Fernandez-Palomo; Esra Güç; Witold W Kilarski; Ruslan Hlushchuk; Jean Laissue; Valentin Djonov
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

Review 5.  Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: A Review.

Authors:  Dorina Coricovac; Cristina Dehelean; Elena-Alina Moaca; Iulia Pinzaru; Tiberiu Bratu; Dan Navolan; Ovidiu Boruga
Journal:  Int J Mol Sci       Date:  2018-05-24       Impact factor: 5.923

Review 6.  Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma.

Authors:  Marta Di Martile; Stefania Garzoli; Rino Ragno; Donatella Del Bufalo
Journal:  Cancers (Basel)       Date:  2020-09-16       Impact factor: 6.639

7.  From Immunosuppression to Immunomodulation - Turning Cold Tumours into Hot.

Authors:  Mariangela Garofalo; Katarzyna Wanda Pancer; Magdalena Wieczorek; Monika Staniszewska; Stefano Salmaso; Paolo Caliceti; Lukasz Kuryk
Journal:  J Cancer       Date:  2022-07-04       Impact factor: 4.478

8.  Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy.

Authors:  Mona Yazdani; Mahdi Hatamipour; Behrang Alani; Hossein Nikzad; Nema Mohamadian Roshan; Javad Verdi; Mahmoud Reza Jaafari; Mahdi Noureddini; Ali Badiee
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

9.  Botanical Therapeutics: Phytochemical Screening and Biological Assessment of Chamomile, Parsley and Celery Extracts against A375 Human Melanoma and Dendritic Cells.

Authors:  Corina Danciu; Istvan Zupko; Andrea Bor; Anja Schwiebs; Heinfried Radeke; Monica Hancianu; Oana Cioanca; Ersilia Alexa; Camelia Oprean; Florina Bojin; Codruta Soica; Virgil Paunescu; Cristina Adriana Dehelean
Journal:  Int J Mol Sci       Date:  2018-11-16       Impact factor: 5.923

10.  Detectability of fluorescent gold nanoparticles under micro-CT and optical projection tomography imaging.

Authors:  Stevo Kozomara; Nancy L Ford
Journal:  J Med Imaging (Bellingham)       Date:  2020-04-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.